All Insights
Exploring the science, practice, and business of medicine.
Exploring the science, practice, and business of medicine.
Showing 10 out of 516 Insights
How health care professionals find "their people" online for professional development and educational scholarship is explored in this Harvard Macy Institute blog post.
David Y. Ting, chief medical information officer of the Massachusetts General Physicians Organization in Boston and co-director of the MGH Center for Innovation in Digital HealthCare, discusses technologies aimed at easing administrative burden and provider burnout.
MedEdPearls December 2019: This MedEdPearls discusses the Ignite session on "Make It Stick," demonstrating how its principles have empowered learners and faculty.
As physicians, nurses, and other health care workers in the United States face increasing pressure to do more with less, there has been growing interest in the benefits of incorporating artistic and humanistic values into medical training to build resilience and wellness.
In this Harvard Macy Institute blog post, Arianne "Cuff" Baker shares her Medical Education Mantra, which serves as a reminder for her to remain actively engaged with the medical education community.
Genomic scientist George Church, PhD, professor of Genetics at Harvard Medical School, discusses approaches to genome editing and applications for organoids in drug discovery and development.
MedEdPearls November 2019: Competency based medical education (CBME) is an outcomes-based time-independent concept that is informing curricular innovation across the country and beyond.
In this Harvard Macy Institute blog post, Sarah Mills discusses how to create engaging lectures.
In this Harvard Macy Institute blog post, current challenges facing the health care system are discussed.
Physician-scientist Anna Greka, MD, PhD, associate professor at Harvard Medical School, founding director of Kidney NExT at Brigham and Women’s Hospital and director of the Broad Institute Kidney Disease Initiative, discusses groundbreaking work on a rare kidney disease, prospects for new therapeutics and collaborating on drug development.